Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibody.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 16, Issue 14, 2002, Pages 2000-2002

  Rader, Christoph ^a   Popkov, Mikhail ^a   Neves, John A ^a   Barbas 3rd , Carlos F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; PEPTIDE LIBRARY; TRANSACTIVATOR PROTEIN; VITRONECTIN RECEPTOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DIVISION; DIRECTED MOLECULAR EVOLUTION; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; GENETICS; HUMAN; IMMUNOLOGY; KAPOSI SARCOMA; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; CELL DIVISION; DIRECTED MOLECULAR EVOLUTION; DRUG DELIVERY SYSTEMS; GENE PRODUCTS, TAT; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, NUDE; MODELS, BIOLOGICAL; PEPTIDE LIBRARY; SARCOMA, KAPOSI;

EID: 0036884547     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0281fje     Document Type: Article

References (0)